Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors

por Centanni, Maddalena, Friberg, Lena E.
Publicado 2020

Bayesian forecasting of tumor size metrics and overall survival

por Krishnan, Sreenath M., Friberg, Lena E.
Publicado 2022

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)

por Sinha, Vikram, Friberg, Lena E., Zhao, Ping
Publicado 2021

Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response

por Bender, Brendan C, Schindler, Emilie, Friberg, Lena E
Publicado 2015

Inter occasion variability in individual optimal design

por Kristoffersson, Anders N., Friberg, Lena E., Nyberg, Joakim
Publicado 2015

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models

por Ibrahim, Eman I. K., Karlsson, Mats O., Friberg, Lena E.
Publicado 2023

Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring

por Netterberg, Ida, Nielsen, Elisabet I., Friberg, Lena E., Karlsson, Mats O.
Publicado 2017

Effects of cladribine tablets on heart rate, atrio‐ventricular conduction and cardiac repolarization in patients with relapsing multiple sclerosis

por Hermann, Robert, Litwin, Jeffrey S., Friberg, Lena E., Dangond, Fernando, Munafo, Alain
Publicado 2019

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against Pseudomonas aeruginosa to Clinical Settings

por Minichmayr, Iris K., Kappetein, Suzanne, Brill, Margreke J. E., Friberg, Lena E.
Publicado 2022

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

por Centanni, Maddalena, Thijs, Abel, Desar, Ingrid, Karlsson, Mats O., Friberg, Lena E.
Publicado 2022

Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime

por Thorsted, Anders, Tano, Eva, Kaivonen, Kia, Sjölin, Jan, Friberg, Lena E., Nielsen, Elisabet I.
Publicado 2020

Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2‐negative breast cancer patients treated with docetaxel

por Krishnan, Sreenath M., Laarif, Sofiene S., Bender, Brendan C., Quartino, Angelica L., Friberg, Lena E.
Publicado 2021

Characterizing variability in warfarin dose requirements in children using modelling and simulation

por Hamberg, Anna-Karin, Wadelius, Mia, Friberg, Lena E, Biss, Tina T, Kamali, Farhad, Jonsson, E Niclas
Publicado 2014

Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel

por Krishnan, Sreenath M., Friberg, Lena E., Bruno, René, Beyer, Ulrich, Jin, Jin Y., Karlsson, Mats O.
Publicado 2021

Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments

por Olsson, Anna, Wistrand-Yuen, Pikkei, Nielsen, Elisabet I., Friberg, Lena E., Sandegren, Linus, Lagerbäck, Pernilla, Tängdén, Thomas
Publicado 2020

Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose

por Zhao, Chenyan, Chirkova, Anna, Rosenborg, Staffan, Palma Villar, Rodrigo, Lindberg, Johan, Hobbie, Sven N, Friberg, Lena E
Publicado 2022

Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow‐Up Time

por Netterberg, Ida, Bruno, René, Chen, Ya‐Chi, Winter, Helen, Li, Chi‐Chung, Jin, Jin Y., Friberg, Lena E.
Publicado 2020

Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance

por Yin, Anyue, van Hasselt, Johan G. C., Guchelaar, Henk-Jan, Friberg, Lena E., Moes, Dirk Jan A. R.
Publicado 2022

Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance

por Yin, Anyue, van Hasselt, Johan G. C., Guchelaar, Henk-Jan, Friberg, Lena E., Moes, Dirk Jan A. R.
Publicado 2022

Continuous infusion of piperacillin‐tazobactam significantly improves target attainment in children with cancer and fever

por Maarbjerg, Sabine F., Thorsted, Anders, Friberg, Lena E., Nielsen, Elisabet I., Wang, Mikala, Schrøder, Henrik, Albertsen, Birgitte K.
Publicado 2021